COVID-19

Shown here is the research team that discovered monoclonal antibodies that protect against COVID-19 in high-risk individuals.

COVID antibody research conducted at VUMC lands national award

A long-acting antibody combination discovered at Vanderbilt University Medical Center that protects against COVID-19 in high-risk individuals has received a gold medal in the 2022 R&D 100 awards program announced Aug. 22 by R&D World Magazine.

Reminder: COVID-19 infection prevention guidelines for all VUMC workforce members

A story of family and faith: Jennifer received a kidney transplant. The donor was Capri, who is married to Dennis. Jennifer is Dennis’ ex-wife. It’s complicated.

The extended family has grown closer as a result of Capri’s generosity. She says her faith led her to the decision.

NAM special publication focuses on COVID lessons learned

A new special publication from the National Academy of Medicine spotlights the opportunity to leverage lessons learned from the pandemic to transform health, health care and health delivery in the United States.

Video vital for telehealth visits

Vanderbilt study of 18,130 telehealth visits at the beginning of the COVID-19 pandemic defines risk factors associated with telehealth access and suggests how health systems can improve access.

The study team included (front row, from left) Kelsey Voss, PhD, Rachel Bonami, PhD, Erin Wilfong, MD, PhD, (back row, from left) Jonathan Irish, PhD, Jeff Rathmell, PhD, and Ivelin Georgiev, PhD.

Vanderbilt team tracks cellular and antibody responses to COVID-19 vaccine

In a technical tour de force, a collaborative team of Vanderbilt researchers has characterized the antigen-specific immune response to the Pfizer SARS-CoV-2 RNA vaccine.

1 3 4 5 6 7 38